Clinical Trial Update: STAAR-3 Clinical Study [Phase 4]

View source ↗

Summary

Phase 4 trial update for STAAR-3 sponsored by Amgen, focusing on chronic kidney disease and chronic renal insufficiency. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: Amgen | Conditions: Chronic Kidney Disease, Chronic Renal Insufficiency | Phase 4 | Status: COMPLETED